Leader Capital Markets Remains Bullish on Teva Pharmaceutical Industries (TEVA)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy healthcare stocks to buy now. In a report released on July 21, Sabina Levi from Leader Capital Markets maintained a Buy rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) with a price target of ILA9,300.00.

Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds is Buying

A close-up shot of various types of medicines on a table, illustrating the specialty and generic products offered by the pharmaceutical company.

In other news, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced a strategic partnership with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on June 16. The partnership aims at the development of investigational TEV-56278, an anti-PD1-IL2 ATTENUKINE therapy.

Teva Pharmaceutical Industries Limited’s (NYSE:TEVA) internally developed ATTENUKINE technology provides a new mechanism of action that potentially offers low toxicity and high efficacy in a range of oncology indications.

The terms of the agreement focus on the acceleration of clinical data generation, granting Fosun Pharma “an exclusive license to develop, manufacture and commercialize TEV-56278 in the Chinese mainland, Hong Kong Special Administrative Region (SAR), Macau SAR and Taiwan region, and select Southeast Asian countries”.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) develops, produces, and sells medicines. Its operations are divided into the US, Europe, and International Markets geographical segments. Each business segment covers the entire product portfolio in that region, including specialty, generics, and over-the-counter (OTC) products.

While we acknowledge the potential of TEVA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TEVA and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.